600 Participants Needed

Personalized Information for Health Care Delivery

(ADViSE Trial)

JT
NA
Overseen ByNora A Metzger, BA MSW
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: VA Office of Research and Development
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment involving Clinician Coaching Sessions and Personalized text messages to patients?

Research shows that personalized text messages can effectively encourage behavior change, especially when they are tailored to the individual's preferences and daily activities. Additionally, patient-clinician communication, such as through secure electronic messaging, can improve patient outcomes by enhancing information retention and providing opportunities for patient-centered communication.12345

How is the treatment of Clinician Coaching Sessions and Personalized text messages to patients unique?

This treatment is unique because it combines personalized communication through clinician coaching and tailored text messages to enhance patient engagement and health outcomes. Unlike traditional treatments, it leverages technology to provide customized health information and support, potentially improving patient-provider communication and empowering patients to make informed health decisions.26789

What is the purpose of this trial?

Expanded availability of virtual care encounters in Primary Care provides new opportunities to improve Veterans' outcomes by aligning encounter modalities with their needs and preferences. Yet, Veterans and their Primary Care physicians (PCPs) lack personalized information about the benefits and costs of different Primary Care modalities that is needed to maximize the value of Primary Care encounters. To address this problem, in this study the investigators will use surveys and interviews to identify what Veterans and PCPs perceive to be the benefits and optimal uses of different Primary Care encounter modalities. They will then supplement their existing system for communicating encounter costs to Veterans and PCPs with new interactive messaging about benefits and optimal uses of different encounter modalities. Finally, this novel Advancing Decisions about Virtual Service Encounters (ADViSE) intervention will be optimized through user-centered refinement before evaluating its effects on Veteran-centered outcomes, use of virtual care, and intermediate health outcomes in a randomized controlled trial (RCT).

Research Team

JT

Jeffrey T. Kullgren, MD MPH MS

Principal Investigator

VA Ann Arbor Healthcare System, Ann Arbor, MI

Eligibility Criteria

This trial is for Veterans and their Primary Care physicians (PCPs) who are interested in optimizing the use of virtual care encounters. It aims to provide personalized information to help decide between different types of primary care services based on individual needs and preferences.

Inclusion Criteria

I've had 3 or more doctor visits in the last year.
Willing and able to receive text messages from the VA Patient Engagement, Tracking, and Long-term Support (PETALS) platform
Able to provide informed consent
See 1 more

Exclusion Criteria

I do not have a diagnosis of mild cognitive impairment, dementia, or a psychotic disorder.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Control Period

Usual care is provided to participants to establish baseline measures

6 months

Intervention

Participants receive the optimized ADViSE intervention with interactive text messages and point-of-care information

6 months

Follow-up

Participants are monitored for changes in healthcare perceptions and outcomes post-intervention

4-8 weeks

Treatment Details

Interventions

  • Clinician Coaching Sessions
  • Personalized text messages to patients
Trial Overview The study tests an intervention called ADViSE, which includes sending personalized text messages to patients and providing coaching sessions for clinicians. The goal is to inform about the benefits and costs of various primary care modalities through surveys, interviews, and interactive messaging.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Receiving the optimized ADviSE InterventionExperimental Treatment2 Interventions
6 months of selected text messages from a library developed and refined in previous study aims.
Group II: Control periodActive Control1 Intervention
Usual care.

Find a Clinic Near You

Who Is Running the Clinical Trial?

VA Office of Research and Development

Lead Sponsor

Trials
1,691
Recruited
3,759,000+

References

The Management of Diabetes in Everyday Life (MODEL) program: development of a tailored text message intervention to improve diabetes self-care activities among underserved African-American adults. [2022]
Look Who's Talking: Application of a Theory-Based Taxonomy to Patient-Clinician E-mail Messages. [2022]
Customized feedback to patients and providers failed to improve safety or quality of diabetes care: a randomized trial. [2022]
Text or Not to Text? A Narrative Review of Texting as a Case Management Intervention. [2021]
Patient preferences and access to text messaging for health care reminders in a safety-net setting. [2022]
Tailoring communications for primary care settings. [2017]
MedTxting: learning based and knowledge rich SMS-style medical text contraction. [2021]
A personalised Healthcare Information Delivery System: pushing customised healthcare information over the WWW. [2004]
How 2 txt: an exploration of crafting public health messages in SMS. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security